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Background: Tracheal intubation without muscle relaxants is usually performed with remifentanil and propofol or
sevoflurane. Remifentanil 1.0 to 4.0 μg·kg-1 and propofol 2.0-3.0 mg·kg-1 or sevoflurane up to 8.0 Vol% provide
acceptable, i.e. excellent or good intubating conditions. We hypothesized that sevoflurane 1.0 MAC would provide
acceptable intubating conditions when combined with propofol and remifentanil.
Methods: Eighty-three patients to be intubated were randomised to two groups. The SEVO group received
propofol 1.5 mg kg-1, remifentanil 0.30 μg kg min-1 and sevoflurane 1.0 MAC; the MR group received the same
doses of propofol and remifentanil plus rocuronium 0.45 mg kg-1. We evaluated intubation and extubation
conditions, mean arterial pressure (MAP), heart rate (HR) and bispectral index (BIS). The vocal cords were examined
for injury by videolaryngoscopy before and 24 hours after surgery.
Results: Acceptable intubating conditions were seen more frequently with rocuronium than with sevoflurane: 97%
versus 82%; p = 0.03; the subscore for vocal cords was comparable: 100% versus 98%. MAP before intubation
decreased significantly compared with the MAP at baseline to the same extent in both groups; ephedrine IV was
given in 15 (SEVO) versus 16 (MR) patients; p = 0.93. BIS at tracheal intubation was 27 (13-65) in the SEVO group,
29 (14-62) in the MR group; p = 0.07. Vocal cord injuries (oedema, haematoma) were similar: 4 patients in each group.
Conclusions: Overall intubating conditions were better when rocuronium was used; the subscore for vocal cords was
comparable. The incidence of side effects was the same in the two groups.
Trial registration: ClinicalTrials.Gov: NCT 01591031.
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Tracheal intubation without neuromuscular blocking
agents (NMBAs) is performed mainly with remifentanil
and propofol [1,2]; alfentanil, fentanyl and sufentanil are
alternative opioids [3-5]. Alternative hypnotic agents are
etomidate, thiopental and sevoflurane [6,7]. Because poor
intubating conditions are associated with vocal cord
injury [3] it is important to achieve good or excellent,* Correspondence: thomas.mencke@googlemail.com
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unless otherwise stated.i.e., acceptable, intubating conditions. Remifentanil, 1.0 to
4.0 μg·kg-1 combined with propofol, provides acceptable
intubating conditions [1,2,4], but these doses may cause
arterial hypotension and severe bradycardia [7,8]. The
remifentanil infusion rate can be reduced when a volatile
anaesthetic such as isoflurane is added rather than propo-
fol [9]. Sevoflurane 8 Vol% (i.e., 4.0 minimal alveolar con-
centration; MAC) combined with remifentanil 2.0 μg·kg-1
provided acceptable intubating conditions in 97% of
patients, but mean arterial pressure (MAP) decreased
by about 25% [7]. We hypothesized that sevoflurane 1.0
MAC would provide clinically acceptable intubatingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sia induction with propofol and a continuous infusion
of remifentanil.Methods
The SEVO (sevoflurane) group received propofol, remifen-
tanil and sevoflurane 1.0 MAC; the MR (muscle relaxant)
group received propofol, remifentanil and rocuronium
0.45 mg·kg-1. The primary outcome measure was the in-
tubation score [10]. Secondary outcome measures were
MAP, heart rate (HR) and bispectral index (BIS); in
addition, we assessed the incidence and severity of vocal
cord injuries at 24 hours after surgery by videolaryngo-
scopy, the incidence and severity of hoarseness and sore
throat up to 72 hours after surgery.Ethics approval and registration
This prospective, randomised, clinical study was conducted
between April 2012 and January 2013 at the University
Hospital of Rostock, Germany. Ethical approval was provided
by the Institutional Review Committee (Ethikkommission
der Universitaet Rostock, Rostock, Germany; registration
number: A 2011 124) on 3 November 2011. The study
was registered at ClinicalTrials.Gov with the number
NCT 01591031.Inclusion and exclusion criteria
After obtaining written informed consent, we studied 88
patients, American Society of Anesthesiologist (ASA)
grade I-III aged 18-80 years, who required orotracheal in-
tubation for ear surgery. Exclusion criteria were a known
or suspected difficult airway, such as mouth opening <
3.5 cm or Mallampati score 4 or Cormack grade 3 and 4;
obesity; disease of the larynx or vocal cords; hoarseness
before surgery; and a preexisting severe vocal cord path-
ology discovered at videolaryngoscopy by an ear-nose-
throat (ENT) physician before surgery.Randomisation and monitoring
A randomisation program was used [11]. Patients in
group MR were monitored with acceleromyography to
achieve maximum neuromuscular block at the time of
tracheal intubation in the MR group, i.e, when the TOF
counts disappeared. Neuromuscular monitoring was
performed with the TOF Watch SX® device (Organon
Teknika, Eppelheim, Germany). Neuromonitoring was
performed in all with the BIS Vista® brain monitoring
system (Aspect Medical Systems, Norwood, MA, USA).
It was used to measure the depth of anaesthesia at time
of tracheal intubation. Blood pressure was measured
non-invasively every 2 minutes during induction of an-
aesthesia and afterwards every 5 minutes.Induction and maintenance of anaesthesia
All patients received midazolam 7.5 mg orally before ar-
rival in the anaesthetic room, where they were given
dexamethasone 4.0 mg IV and ondansetrone 4.0 mg IV.
Induction of anaesthesia was standardised: all patients
received remifentanil 0.30 μg·kg·min-1 for three minutes,
after which propofol 1.5 mg·kg-1 was given (if necessary
30 mg was supplemented). After the propofol, the SEVO
group received sevoflurane at an inspired concentration of
3.0-3.5 Vol% (fresh gas flow 8 l·min-1). After 2-3 minutes,
when the endtidal sevofluane concentration reached
1.0 MAC (stable for 20 s), intubation was performed.
MAC was calculated from the age of the patient with the
software from the Primus® anaesthetic machine (Dräger
Medical Germany, Lübeck, Germany). The sevoflurane
was discontinued after intubation. In the MR group, after
propofol, rocuronium 0.45 mg·kg-1 was given after cali-
bration of the TOF watch SX. If maximum block did not
occur, a further 0.15 mg·kg-1 rocuronium was added. The
trachea was intubated when maximum block was achieved,
by the same anaesthesiologist each time.
Maintenance of anaesthesia was by propofol 4.0 –
6.0 mg·kg·h-1 and remifentanil 0.20-0.30 μg·kg·min-1 in
both groups. Ephedrine 5-10 mg IV was given if systolic
pressure decreased by 20% and/or below 100 mmHg and
atropine IV if the HR decreased below 45 min-1. The pa-
tients were extubated when they opened their eyes and/
or began to cough. They were then moved to the posta-
naesthesia care unit (PACU).
Intubating conditions, intubating variables and
extubating conditions
Intubating conditions were assessed according to the
GCRP guidelines (see Table 1) [10]. Extubating conditions
assessed during removal of the tracheal tube were defined
as follows: excellent = no coughing and no movement of
the limbs, good = slight coughing or slight movement of
the limbs or both; poor = sustained coughing and/or vig-
orous movement of the limbs during extubation. Intubat-
ing variables were assessed: application of back upward
right pressure (BURP), Cormack and Lehane grade, time
for intubation and number of intubation attempts (see
Appendix). We used RAE tubes (Mallinckrodt®, Covidien,
Dublin, Irland) standardized to 8.0 mm for men and
7.0 mm for women. Cuff pressure was measured and ad-
justed continuously below 25 cm H20 by a cuff pressure
monitor. No gastric tubes or intubation stylets were used.
Hoarseness and sore throat
Hoarseness and sore throat were assessed in the PACU
and daily up to 72 hours by a physician blinded to the
patient’s group assignment. The incidence and severity
of hoarseness (defined as change in the acoustic quality)
and sore throat (defined as a continuous throat pain)






Variable Excellent Good Poor
Laryngoscopy





Position Abducted Intermediate Closed
Movement None Moving Closing
Reaction to tube insertion
or cuff inflation
Movement of limbs None Slight Vigorous
Coughing None Slight Sustained
Intubating conditions: excellent = all qualities are excellent; good = all qualities
are excellent or good; poor = any quality is poor. Excellent and good
intubating conditions are summarised as clinically acceptable conditions [10].
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[12,13].
Vocal cord injuries
All patients underwent laryngoscopy before surgery by an
ENT physician who was blinded to the patient’s group.
Slight changes, such as erythema, and vocal cord injuries,
such as oedema, haematoma and granuloma by videolar-
yngoscopy (see Appendix) were noted. The recordings be-
fore and after surgery were compared; any changes were
assessed as to the possibility that they could be caused by
intubation.
Statistical analysis
We used the SigmaStat® for Windows Version 3.5, (Systat
Sotware Inc., San Jose, California, USA). Demographic
data were analysed using Mann-Whitney U-test or t-test.
Comparisons between the study groups were performed
using the χ2test, Fisher’s exact test or Kruskal-Wallis
ANOVA test. Results were considered statistically signifi-
cant when p < 0.05.
A sample size calculation assumed an incidence of ac-
ceptable intubating conditions of 100% in the rocuro-
nium group and 75% in the sevoflurane group.
Therefore we needed 66 patients (33 patients in each
group; α = 0.05, 1-β = 80%).
Results
We randomised 83 patients; 43 to the SEVO group and
40 to the MR group (see Figure 1). Patient characteris-
tics were comparable (Table 2). BMI was less, but not
significantly in the SEVO group (p = 0.06). The duration
of anaesthesia was significantly greater in the MR group(p = 0.01). BIS values and use of ephedrine were similar
(Table 2). Table 3 shows the haemodynamic response to
tracheal intubation.
Intubating conditions, intubating variables and
extubating conditions
Tracheal intubation was possible in all patients, but two
patients from the SEVO group could only be intubated
after administration of rocuronium (see Figure 1). The
vocal cords were closed and did not open after propofol
30 mg IV; to avoid vocal cord injuries, rocuronium
0.45 mg·kg-1 was given. Overall intubating conditions
were not significantly better in group MR (p = 0.06). How-
ever, acceptable intubating conditions (excellent and good)
were significantly more common (p = 0.03; Figure 2). The
subscores for the vocal cords were not significantly differ-
ent, but the subscore reaction to tube insertion or cuff
inflation was significantly better in group MR (p = 0.02;
Figures 3, 4 and 5). Intubating variables and extubating
conditions are shown in Table 4.
Hoarseness and sore throat
The overall incidence of hoarseness was 21.5%, with no
significant difference between the groups. The overall in-
cidence of sore throat was 52%, again with no significant
difference between groups. No patient suffered from
hoarseness or sore throat exceeding 72 hours.
Vocal cord injuries
The overall incidence of vocal cord injuries was 12.5%
(Table 5). There were two haematomas and six cases of
oedema, but no granulomas. Slight changes, such as ery-
thema, were found in 13 patients in the SEVO group
and eight in the MR group (n.s.).
Discussion
Tracheal intubation with propofol 1.5 mg·kg-1, remifen-
tanil 0.30 μg·kg-1·min-1 and sevoflurane 1.0 MAC was
feasible and safe, but intubating conditions were not as
good as in the rocuronium group. Acceptable intubating
conditions were present in 82% of the patients in the
SEVO group, and the subscore for the vocal cords was
acceptable in 98%. MAP and ephedrine application were
similar in the two groups, as were vocal cord injuries.
Tracheal intubation without NMBAs is performed
more frequently, especially in ambulatory surgery [14].
In Germany in 2005, 20% of elective tracheal intubations
were performed without NMBAs [15]. The laryngeal
mask offers an alternative, but for surgery in the prone
position, laparoscopic or ENT surgery, tracheal intub-
ation is essential [16]. Intubation without NMBAs avoids
postoperative residual blockade and allergic reactions to
muscle relaxants.
Table 2 Patient characteristics, duration of anaesthesia,
BIS and ephedrine administration
SEVO group MR group P
(n = 39) (n = 40)
Age (yr) 48 ± 17 50 ± 16 0.67
Weight (kg) 79.6 ± 15 83.8 ± 16 0.23
Height (cm) 173 ± 11 172 ± 9 0.70
Body mass index (kg·m-2) 26.5 ± 3.7 28.2 ± 4.3 0.06
Gender ratio (female/male) 16/23 16/24 0.89
ASA I/II/III 5/30/4 3/33/4 0.73
Duration of anaesthesia (min) 81 (38-193) 121 (48-214) 0.01
BIS at tracheal intubation 27 (13-65) 29 (14-62) 0.07
BIS at tracheal extubation 72 (43-91) 71 (42-88) 0.89
Administration of ephedrine (n) 15 (38) 16 (40) 0.93
Values are mean ± SD, or numbers (%) or median (range).
BIS = bispectral index.
SEVO group = Induction of anaesthesia with sevoflurane.
MR group = Induction of anaesthesia with rocuronium.
Table 3 Induction of anaesthesia and haemodynamic
response to tracheal intubation
SEVO group MR group P
(n = 39) (n = 40)
Mean arterial pressure (mmHg)
Preinduction 92 ± 11 95 ± 11 0.18
Postinduction 65 ± 9* 65 ± 8* 0.98
Postintubation 67 ± 6* 68 ± 9* 0.34
Heart rate (beats/min)
Preinduction 71 ± 12 77 ± 14 0.05
Postinduction 63 ± 10* 65 ± 11* 0.51
Postintubation 60 ± 10* 65 ± 10* 0.03
Values are mean ± SD. *p < 0.05 versus preinduction values.
Preinduction = before induction of anaesthesia; Postinduction = 3 min after
induction of anaesthesia but before tracheal intubation; Postintubation = 2 min
after tracheal intubation.
SEVO group = Induction of anaesthesia with sevoflurane.
MR group = Induction of anaesthesia with rocuronium.
Figure 1 Flow chart of patient distribution.
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Figure 4 Patients (%) with excellent (black bars), good (grey
bars) and poor intubation conditions (white bars) for subscore
vocal cords. MR group versus SEVO group: p = 0.59. SEVO group =
Induction of anaesthesia with sevoflurane. MR group = Induction of
anaesthesia with rocuronium.
Figure 2 Patients (%) with excellent (black bars), good (grey
bars) and poor intubation conditions (white bars). *p = 0.06 MR
group versus SEVO group overall; p = 0.029 clinically acceptable
(excellent and good) conditions. SEVO group = Induction of
anaesthesia with sevoflurane. MR group = Induction of anaesthesia
with rocuronium.
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provided acceptable intubating conditions [1,2,4,17].
Remifentanil 2 μg·kg-1 and propofol 2.0 mg·kg-1 were
sufficient to obtain excellent intubating conditions in 11
of 12 healthy volunteers [17]. The drugs were given over 5
to 10 seconds, the propofol immediately after the remifen-
tanil, a method which is safe in healthy volunteers or
young patients, but not for patients of ASA grade II or
III. As much as 4.0 μg·kg1 may be necessary to obtain
excellent intubating conditions [18]. Remifentanil ≥
2 μg·kg-1 is not suitable for old patients or those withFigure 3 Patients (%) with excellent (black bars), good (grey
bars) and poor intubation conditions (white bars) for subscore
laryngoscopy. *p = 0.06 MR group versus SEVO group. SEVO group =
Induction of anaesthesia with sevoflurane. MR group = Induction of
anaesthesia with rocuronium.cardiovascular disease because it is associated with ar-
terial hypotension and bradycardia [18]. In one obser-
vational study the choice of agent depended on the
decision of the anesthesiologist [5]. Acceptable intub-
ating conditions were found in 98.2% of the patients in
the relaxant-free intubating group; post-intubation laryn-
geal symptoms like sore throat and dysphonia were com-
parable between groups. In the relaxant-free group the
median dosage of propofol was 3.64 mg·kg-1, supple-
mented with sufentanil [5]. Arterial hypotension was ob-
served in 14% of patients, to a similar degree in the two
groups. Patients in the relaxant-free group, however, were
significantly younger and in better ASA grades [5]. OthersFigure 5 Patients (%) with excellent (black bars), good (grey
bars) and poor intubation conditions (white bars) for subscore
reaction to tube insertion or cuff inflation. *p = 0.02 MR group
versus SEVO group. SEVO group = Induction of anaesthesia with
sevoflurane. MR group = Induction of anaesthesia with rocuronium.







(n = 39) (n = 40)
Intubating variables
Mallampati I/II/III 20/19/0 18/21/1 0.55
Cormack grades 1/2 26/13 24/16 0.70
Application of BURP 8 12 0.48
Time for intubation (s) 21 ± 17 19 ± 12 0.44
Attempts (n) 1/2 36/3 35/5 0.71
Extubating conditions
Coughing and movement of
limbs excellent/good/poor
1/21/17 3/26/11 0.25
Values are mean ± SD or numbers. BURP = back upward right pressure.
SEVO group = Induction of anaesthesia with sevoflurane.
MR group = Induction of anaesthesia with rocuronium.
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is more common [19].
Significantly fewer patients in our SEVO group had ac-
ceptable intubating conditions. The subscore vocal
cords, however, was acceptable in all SEVO patients ex-
cept one. Sevoflurane relaxes the bronchial muscles and
possibly also the laryngeal muscles [20]. The other sub-
scores, however, were significantly worse in the SEVO
group.
Sevoflurane has been used as the sole agent for tra-
cheal intubation; the ED95 for tracheal intubation was
8.07% (end-tidal concentration) [21]. Conditions after in-
duction with sevoflurane 6% and N2O 66% in O2 were
comparable to those with succinylcholine 1.5 mg·kg-1
[22]. This technique has been proposed for patients in
whom succinylcholine is contraindicated [22]. Mean ar-
terial pressure and heart rate were significantly lower
immediately before tracheal intubation with sevoflurane.
Adding remifentanil 2.0 μg·kg-1 to sevoflurane 8 Vol%Table 5 Vocal cord injuries and erythema
SEVO group MR group P
(n = 31) (n = 33)
Incidence of injuries
Haematoma, oedema 4 (13) 4 (12) 1.00
Granuloma 0 0 -
Slight changes
Erythema 13 (42) 8 (24) 0.21
Side (erythema and injuries)
Bilateral 16 11 0.22
Left 0 1 (erythema)
Right 1 (hematoma) 0
Values are numbers (%).
SEVO group = Induction of anaesthesia with sevoflurane.
MR group = Induction of anaesthesia with rocuronium.resulted in acceptable intubating conditions in 29 of 30
patients [7], a similar incidence to intubating conditions
with rocuronium 0.6 mg·kg-1 [23]. Cros et al. applied a
modified Dixon’s up-and-down method to remifentanil
1.0 μg·kg-1 followed by an infusion of 0.25 μg·kg-1·min-1,
increasing or decreasing sevoflurane in 0.5% steps. The
concentration of sevoflurane for acceptable intubating
conditions was 2.5 ± 0.7% [24]. Sevoflurane 8 Vol% com-
bined with remifentanil 2.0 μg·kg-1 caused a significant
reduction of mean arterial pressure in young ambulatory
patients (median age 16 and 18 years) [7]. In our study,
MAP decreased in both groups by about 30%, and ephe-
drine use was similar. MAP decreased more than ex-
pected in our patients (mean ages 48 and 50 years), who
were much older than those of Cagiran et al. [7].
Our study included patients of ASA III grade with cor-
onary artery and cerebrovascular disease. The heart rate
was significantly lower after tracheal intubation with
sevoflurane, which is advantageous for patients with cor-
onary heart disease.
Avoiding neuromuscular blockade may increase the risk
of difficult mask ventilation [25,26]. In a Danish observa-
tional study, tracheal intubation was difficult in 5.1% of
103,812 patients; avoiding neuromuscular blockade was
one risk factor in the multivariate analysis (odds ratio
1.48) [25]. Neuromuscular blockade with rocuronium fa-
cilitated mask ventilation significantly compared with sa-
line; in all 42 patients with rocuronium, ventilation was
possible by mask [26]. In an observational study of 53041
patients in whom mask ventilation was attempted, it
was impossible in 77 (0.15%); 73 patients had received
a neuromuscular blocking drug during management of
the airway and neuromuscular blockade did not improve
matters [27]. Changes caused by radiotherapy of the neck
were the most important risk factor for impossible
mask ventilation [27]. Difficult mask ventilation com-
bined with difficult laryngoscopy was observed in 698 pa-
tients (0.40%) from 176,679 patients [28]. Independent
risk factors for difficult mask ventilation combined with
difficult laryngoscopy included radiotherapy changes, the
presence of teeth, Mallampati III or IV and male sex. The
impact of neuromuscular blocking agents could not be
assessed [28].
Tracheal intubation with propofol and fentanyl alone
was associated with a greater frequency and severity of
hoarseness and vocal cord injuries compared with a
group receiving these drugs and atracurium; intubating
conditions were better with atracurium [3]. Without
rocuronium, there was more hoarseness and intubating
conditions were worse [17]. Nevertheless, Bouvet et al.
showed that propofol and remifentanil were associated
with a similar incidence of hoarseness and vocal cord in-
juries to cisatracurium [29], although fibroscopic exam-
ination was done 48 hours after surgery only in patients
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ID of 6.5 or 7.0 mm were used [29]. The incidence of
vocal cord injuries in patients receiving NMBAs was up
to 27%, and 42% in patients receiving propofol and fen-
tanyl without NMBAs [3,30-33]. In the present study,
however, we used remifentanil instead of fentanyl, and
also sevoflurane. Vocal cord injuries such as haematoma
and oedema were present in our study in 12.5%; the inci-
dence of erythema was comparable between groups. We
suppose that sevoflurane contributed to this low inci-
dence of vocal cord injuries because the intubating con-
ditions at the vocal cords were clinically acceptable in
98%. Obregon et al. showed that adding sevoflurane to
propofol and remifentanil gave the same incidence of
hoarseness as propofol, remifentanil and rocuronium
[34]. We confirmed these results; in addition, we showed
that laryngeal injuries were not more common under
sevoflurane anaesthesia. Vocal cord injuries may occur
during tracheal intubation, during surgery and at the
end of anaesthesia, when the tube is removed. Therefore,
we assessed not only intubating conditions, but also
extubating conditions to reveal possible risk factors for
vocal cord injuries. The duration of anaesthesia was sig-
nificantly greater in the MR group, which was unexpected
as the patients were randomised. Duration of anaesthesia
exceeding five hours is a risk factor for hoarseness or sore
throat [35,36]; our anaesthetics lasted less than four hours.
The head was not moved during ear surgery; therefore, we
suppose that duration of anaesthesia had no additional ef-
fect on laryngeal morbidity.
Our study has two more limitations. Firstly, it did not
include any patients with the criteria of difficult intub-
ation because we wanted to have comparable patients
in both groups. Second, the investigator who assessed
conditions at intubation could not be blinded as to the
presence of sevoflurane. However, the investigator who
studied hoarseness and sore throat up to 72 hours was
blinded as was the ENT physician who performed the
videolaryngoscopy.
Conclusions
In conclusion, we showed that intubating conditions
with propofol 1.5 mg·kg-1, remifentanil 0.30 μg·kg-1·min-1
and sevoflurane 1.0 MAC-instead of rocuronium
0.45 mg·kg-1-were acceptable in 82% of patients al-
though conditions were better with rocuronium. The
absence of a neuromuscular blocking agent did not affect
the incidence and severity of vocal cord injuries.
Appendix
Hoarseness, sore throat and vocal cord pathologies
A. Hoarseness [3]
Do you have any hoarseness?
No = 0; yes was graded as follows:1 = noticed by patient, 2 = obvious to observer, 3 =
aphonia.
B. Sore throat [13]
Do you have any sore throat?
No = 0; if yes, sore throat was graded as follows: 1 =mild
(pain with deglutition), 2 =moderate (pain present con-
stantly and increasing with deglutition), 3 = severe (pain
interfering with eating and requiring analgesic medication).
C. Vocal cord pathologies [3,30,33]
Location: unilateral (left or right vocal cord) or bilat-
eral (both vocal cords).
Morphology:
– Slight changes: erythema = redness of the mucosa.
– Vocal cord injuries: oedema = swollen mucosa at
the vocal folds, haematoma = bleeding into vocal cord,
granuloma = granulation tissue remains as chronic,
localised, rounded tissue.
D. Intubating variables
– Time for intubation = time in seconds from the
initial inserting of the laryngoscope into the patient’s
mouth until inflation of the cuff.
– Number of intubating attempts.
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